Advertisement

Breast Cancer Research and Treatment

, Volume 93, Issue 3, pp 261–270 | Cite as

Estrogen Metabolizing Polymorphisms and Breast Cancer Risk Among Older White Women

  • Francesmary ModugnoEmail author
  • Joseph M. Zmuda
  • Douglas Potter
  • Chao Cai
  • Elad Ziv
  • Steven R. Cummings
  • Katie L.  Stone
  • Phillip A. Morin
  • Deborah Greene
  • Jane A. Cauley
Epidemiology

Summary

Objective. To investigate breast cancer risk according to metabolizing genes polymorphisms in older women.

Methods. A subset (43.8%) of 4248 older, white women from the Study of Osteoporotic Fractures (SOF) were genotyped for the catechol-O-methyltransferase (COMT) Val108Met polymorphism and the CYP1A1*2C locus. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the associations between genotypes and breast cancer while controlling for potential confounders.

Results. During a mean follow up of 12.4 years, 252 women (5.9%) developed breast cancer. The HR (95% CI) for breast cancer was 1.24 (0.87–1.75) for COMT Val/Met and 1.35 (0.93–1.97) for COMT Met/Met . No interactions with lifestyle and reproductive factors were found. The HR associated with the CYP1A1*2C Val allele was 0.80 (0.46, 1.39) with little evidence for interactions with lifestyle or reproductive factors.

Conclusions. Among older white women, neither the COMT Val108/158Met polymorphism nor the CYP1A*2C Val allele plays a major role in breast cancer risk either alone or in combination with lifestyle and reproductive factors.

Key words

breast neoplasms epidemiology estrogen metabolism genetic polymorphisms prospective cohort study 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Clemons, M, Goss, P 2001Estrogen and the risk of breast cancerN Engl J Med344276285CrossRefPubMedGoogle Scholar
  2. 2.
    Cauley, JA, Lucas, FL, Kuller, LH, Vogt, MT, Browner, WS, Cummings, SR 1996Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Reasearch groupJama27614041408CrossRefPubMedGoogle Scholar
  3. 3.
    Liehr, JG, Fang, WF, Sirbasku, DA, Ari-Ulubelen, A 1986Carcinogenicity of catechol estrogens in Syrian hamstersJ Steroid Biochem24353356CrossRefPubMedGoogle Scholar
  4. 4.
    Cavalieri, EL, Stack, DE, Devanesan, PD, Todorovic, R, Dwivedy, I, Higginbotham, S,  et al. 1997Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiatorsProc Natl Acad Sci USA941093710942CrossRefPubMedGoogle Scholar
  5. 5.
    Yager, JD, Liehr, JG 1996Molecular mechanisms of estrogen carcinogenesisAnnu Rev Pharmacol Toxicol36203232CrossRefPubMedGoogle Scholar
  6. 6.
    Zhu, BT, Conney, AH 1998Functional role of estrogen metabolism in target cells: review and perspectivesCarcinogenesis19127CrossRefPubMedGoogle Scholar
  7. 7.
    Modugno, F, Knoll, C, Kanbour-Shakir, A, Romkes, M 2003A potential role for the estrogen-metabolizing cytochrome P450 enzymes in human breast carcinogenesisBreast Cancer Res Treat82191197CrossRefPubMedGoogle Scholar
  8. 8.
    Lippert, TH, Seeger, H, Mueck, AO 2000The impact of endogenous estradiol metabolites on carcinogenesisSteroids65357369CrossRefPubMedGoogle Scholar
  9. 9.
    Mitrunen, K, Hirvonen, A 2003Molecular epidemiology of sporadic breast cancer The role of polymorphic genes involved in oestrogen biosynthesis and metabolismMutat Res544941CrossRefPubMedGoogle Scholar
  10. 10.
    Raftogianis R, Creveling C, Weinshilboum R, Weisz J: Estrogen metabolism by conjugation. J Natl Cancer Inst Monogr : 113–124, 2000 Google Scholar
  11. 11.
    Zhu, BT, Conney, AH 1998Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis?Cancer Res5822692277PubMedGoogle Scholar
  12. 12.
    Ho, GH, Luo, XW, Ji, CY, Foo, SC, Ng, EH 1998Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer riskAnn Acad Med Singapore27294299PubMedGoogle Scholar
  13. 13.
    Fowke, JH, Qi, D, Bradlow, HL, Shu, XO, Gao, YT, Cheng, JR,  et al. 2003Urinary estrogen metabolites and breast cancer: differential pattern of risk found with pre- versus post-treatment collectionSteroids686572CrossRefPubMedGoogle Scholar
  14. 14.
    Kabat, GC, Chang, CJ, Sparano, JA, Sepkovie, DW, Hu, XP, Khalil, A,  et al. 1997Urinary estrogen metabolites and breast cancer: a case-control studyCancer Epidemiol Biomarkers Prev6505509PubMedGoogle Scholar
  15. 15.
    Meilahn, EN, Stavola, B, Allen, DS, Fentiman, I, Bradlow, HL, Sepkovic, DW,  et al. 1998Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-upBr J Cancer7812501255PubMedGoogle Scholar
  16. 16.
    Muti, P, Bradlow, HL, Micheli, A, Krogh, V, Freudenheim, JL, Schunemann, HJ,  et al. 2000Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal womenEpidemiology11635640CrossRefPubMedGoogle Scholar
  17. 17.
    Yoo, HJ, Sepkovic, DW, Bradlow, HL, Yu, GP, Sirilian, HV, Schantz, SP 2001Estrogen metabolism as a risk factor for head and neck cancerOtolaryngol Head Neck Surg124241247CrossRefPubMedGoogle Scholar
  18. 18.
    Zheng W, Dunning L, Jin F, Holtzman J. Correspondence re: G. C. Kabat et al.: Urinary estrogen metabolites and breast cancer: a case–control study. Cancer Epidemiol., Biomark. Prev. 6: 505–509, 1997. Cancer Epidemiol Biomarkers Prev 7: 85–86, 1998Google Scholar
  19. 19.
    Adlercreutz, H, Gorbach, SL, Goldin, BR, Woods, MN, Dwyer, JT, Hamalainen, E 1994Estrogen metabolism and excretion in Oriental and Caucasian womenJ Natl Cancer Inst8610761082PubMedGoogle Scholar
  20. 20.
    Riza, E, dos Santos Silva, I, Stavola, B, Bradlow, HL, Sepkovic, DW, Linos, D,  et al. 2001Urinary estrogen metabolites and mammographic parenchymal patterns in postmenopausal womenCancer Epidemiol Biomarkers Prev10627634PubMedGoogle Scholar
  21. 21.
    Ursin, G, London, S, Stanczyk, FZ, Gentzschein, E, Paganini-Hill, A, Ross, RK,  et al. 1997A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancerEnviron Health Perspect105 601605PubMedGoogle Scholar
  22. 22.
    Bertocci, B, Miggiano, V, Prada, M, Dembic, Z, Lahm, HW, Malherbe, P 1991Human catechol-O-methyltransferase: cloning and expression of the membrane-associated formProc Natl Acad Sci USA8814161420PubMedGoogle Scholar
  23. 23.
    Lundstrom, K, Salminen, M, Jalanko, A, Savolainen, R, Ulmanen, I 1991and characterization of human placental catechol-O-methyltransferase cDNADNA Cell Biol10181189PubMedGoogle Scholar
  24. 24.
    Hayashi, SI, Watanabe, J, Nakachi, K, Kawajiri, K 1991PCR detection of an A/G polymorphism within exon 7 of the CYP1A1 geneNucleic Acids Res194797Google Scholar
  25. 25.
    Dawling, S, Roodi, N, Mernaugh, RL, Wang, X, Parl, FF 2001Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoformsCancer Res6167166722PubMedGoogle Scholar
  26. 26.
    Syvanen, AC, Tilgmann, C, Rinne, J, Ulmanen, I 1997Genetic polymorphism of catechol-O-methyltransferase (COMT): correlation of genotype with individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and parkinsonian patients in FinlandPharmacogenetics76571PubMedGoogle Scholar
  27. 27.
    Landi, MT, Bertazzi, PA, Shields, PG, Clark, G, Lucier, GW, Garte, SJ,  et al. 1994Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humansPharmacogenetics4242246PubMedGoogle Scholar
  28. 28.
    Ambrosone, CB, Freudenheim, JL, Graham, S, Marshall, JR, Vena, JE, Brasure, JR,  et al. 1995Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer riskCancer Res5534833485PubMedGoogle Scholar
  29. 29.
    Bailey, LR, Roodi, N, Verrier, CS, Yee, CJ, Dupont, WD, Parl, FF 1998Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African AmericansCancer Res586570PubMedGoogle Scholar
  30. 30.
    Basham, VM, Pharoah, PD, Healey, CS, Luben, RN, Day, NE, Easton, DF,  et al. 2001Polymorphisms in CYP1A1 and smoking: no association with breast cancer riskCarcinogenesis2217971800CrossRefPubMedGoogle Scholar
  31. 31.
    Ishibe, N, Hankinson, SE, Colditz, GA, Spiegelman, D, Willett, WC, Speizer, FE,  et al. 1998Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses’ Health StudyCancer Res58667671PubMedGoogle Scholar
  32. 32.
    Taioli, E, Trachman, J, Chen, X, Toniolo, P, Garte, SJ 1995A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American womenCancer Res5537573758PubMedGoogle Scholar
  33. 33.
    Huang, CS, Chern, HD, Chang, KJ, Cheng, CW, Hsu, SM, Shen, CY 1999Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a␣multigenic study on cancer susceptibilityCancer Res5948704875PubMedGoogle Scholar
  34. 34.
    Lavigne, JA, Helzlsouer, KJ, Huang, HY, Strickland, PT, Bell, DA, Selmin, O,  et al. 1997An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancerCancer Res5754935497PubMedGoogle Scholar
  35. 35.
    Yim, DS, Park, SK, Yoo, KY, Yoon, KS, Chung, HH, Kang, HL,  et al. 2001Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancerPharmacogenetics11279286CrossRefPubMedGoogle Scholar
  36. 36.
    Thompson, PA, Shields, PG, Freudenheim, JL, Stone, A, Vena, JE, Marshall, JR,  et al. 1998Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer riskCancer Res5821072110PubMedGoogle Scholar
  37. 37.
    Millikan, RC, Pittman, GS, Tse, CK, Duell, E, Newman, B, Savitz, D,  et al. 1998Catechol-O-methyltransferase and breast cancer riskCarcinogenesis1919431947CrossRefPubMedGoogle Scholar
  38. 38.
    Wedren, S, Rudqvist, TR, Granath, F, Weiderpass, E, Ingelman-Sundberg, M, Persson, I,  et al. 2003Catechol-O-methyltransferase gene polymorphism and post-menopausal breast cancer riskCarcinogenesis24681687CrossRefPubMedGoogle Scholar
  39. 39.
    Mitrunen, K, Jourenkova, N, Kataja, V, Eskelinen, M, Kosma, VM, Benhamou, S,  et al. 2001Polymorphic catechol-O-methyltransferase gene and breast cancer riskCancer Epidemiol Biomarkers Prev10635640PubMedGoogle Scholar
  40. 40.
    Goodman, JE, Lavigne, JA, Wu, K, Helzlsouer, KJ, Strickland, PT, Selhub, J,  et al. 2001COMT genotype, micronutrients in the folate metabolic pathway and breast cancer riskCarcinogenesis2216611665CrossRefPubMedGoogle Scholar
  41. 41.
    Cummings, SR, Black, DM, Nevitt, MC, Browner, WS, Cauley, JA, Genant, HK,  et al. 1990Appendicular bone density and age predict hip fracture in women The Study of Osteoporotic Fractures Research GroupJama263665668CrossRefPubMedGoogle Scholar
  42. 42.
    Morin, PA, Saiz, R, Monjazeb, A 1999High-throughput single nucleotide polymorphism genotyping by fluorescent 5′ exonuclease assayBiotechniques27538540542, 544 passimPubMedGoogle Scholar
  43. 43.
    Cheng, S, Grow, MA, Pallaud, C, Klitz, W, Erlich, HA, Visvikis, S,  et al. 1999A multilocus genotyping assay for candidate markers of cardiovascular disease riskGenome Res9936949CrossRefPubMedGoogle Scholar
  44. 44.
    IARC (1987) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Lyon:IARC PressGoogle Scholar
  45. 45.
    Li, D, Wang, M, Dhingra, K, Hittelman, WN 1996Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiologyCancer Res56287293PubMedGoogle Scholar
  46. 46.
    Perera, FP, Estabrook, A, Hewer, A, Channing, K, Rundle, A, Mooney, LA,  et al. 1995Carcinogen-DNA adducts in human breast tissueCancer Epidemiol Biomarkers Prev4233238PubMedGoogle Scholar
  47. 47.
    Rundle, A, Tang, D, Hibshoosh, H, Estabrook, A, Schnabel, F, Cao, W,  et al. 2000The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancerCarcinogenesis2112811289CrossRefPubMedGoogle Scholar
  48. 48.
    Palmer, JR, Rosenberg, L 1993Cigarette smoking and the risk of breast cancerEpidemiol Rev15145156PubMedGoogle Scholar
  49. 49.
    Park, TW, Yoon, KS, Kim, JH, Park, WY, Hirvonen, A, Kang, D 2002Functional catechol-O-methyltransferase gene polymorphism and susceptibility to schizophreniaEur Neuropsychopharmacol12299303CrossRefPubMedGoogle Scholar
  50. 50.
    Malhotra, AK, Kestler, LJ, Mazzanti, C, Bates, JA, Goldberg, T, Goldman, D 2002A functional polymorphism in the COMT gene and performance on a test of prefrontal cognitionAm J Psychiatr159652654CrossRefPubMedGoogle Scholar
  51. 51.
    Brandt, PA, Spiegelman, D, Yaun, SS, Adami, HO, Beeson, L, Folsom, AR,  et al. 2000analysis of prospective cohort studies on height, weight, and breast cancer riskAm J Epidemiol152514527CrossRefPubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • Francesmary Modugno
    • 1
    • 2
    Email author
  • Joseph M. Zmuda
    • 1
  • Douglas Potter
    • 2
    • 3
  • Chao Cai
    • 2
  • Elad Ziv
    • 4
  • Steven R. Cummings
    • 5
  • Katie L.  Stone
    • 4
  • Phillip A. Morin
    • 6
  • Deborah Greene
    • 7
  • Jane A. Cauley
    • 1
  1. 1.Department of Epidemiology, Graduate School of Public HealthUniversity of PittsburghUSA
  2. 2.University of Pittsburgh Cancer InstitutePittsburghUSA
  3. 3.Department of Biostatistics, Graduate School of Public HealthUniversity of PittsburghPittsburghUSA
  4. 4.Department of MedicineUniversity of California (San Francisco)San FranciscoUSA
  5. 5.Director of Clinical Research, San Francisco Coordinating CenterCalifornia Pacific Medical Center Research InstituteSan FranciscoUSA
  6. 6.Axys Pharmaceuticals, Inc. Southwest Fisheries Science CenterSan Francisco, La JollaUSA
  7. 7.Roche Molecular SystemsPleasantonUSA

Personalised recommendations